Ocular Inflammation Treatment Market – Global Market Size, Strategic Growth Drivers, Risk Assessment Framework, Regulatory Landscape Review, Competitive Intensity Mapping & Long-Term Industry Outlook to 2029
Overview
Global Ocular inflammation treatment market is expected to reach US$ 262.02 Mn. at a CAGR of 6 during the forecast period 2029.
This is a comprehensive report analyzing the current market. The word uvea (referring to grape or grape-like), also called uveal layer or vascular tunic is the pigmented in middle of the three concentric layers that make a human eye. An inflamed ocular is a condition when uvea turns swollen, red and painful.
To know about the Research Methodology:-Request Free Sample Report
This condition causes irritations, burning, redness, blurred vision, sensitivity to light, irregularly shaped pupil, dark spots in vision basically and in worst cases, it causes permanent blindness.
Key Highlights:
Global market analysis and forecast, in terms of value.
Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global market
Global market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided.
The Global market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study.
Global market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation.
Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled.
Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global market are also profiled.
This study has done to provide information about the global market, related market and hence to show opportunities, major global revenue makers in this field.
The scope of the Ocular inflammation treatment market : Inquire before buying
| Global Ocular Inflammation Treatment Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2022 | Forecast Period: | 2023-2029 |
| Historical Data: | 2018 to 2022 | Market Size in 2022: | US $ 174.25 Mn. |
| Forecast Period 2023 to 2029 CAGR: | 6% | Market Size in 2029: | US $ 262.02 Mn. |
| Segments Covered: | by treatment type | Anterior uveitis Intermediate uveitis Posterior uveitis Pan- uveitis or Diffuse uveitis |
|
| by Type | Analgesics Antibodies Antifungal Antiviral rticosteroids Cycloplegic agents Immunosuppressant Monoclonal antibodies |
||
| by uvea | Infectious Non-infectious Systemic disorders Side effect of drug |
||
| by Pathophysiology | Immunological factor Infectious factor Genetic factor |
||
| by channel of distribution | Online channel Retail pharmacies Hospital pharmacies Small drug stores Home delivery |
||
Ocular Inflammation Treatment Market, by Region
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
North America (United States, Canada and Mexico)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Ocular inflammation treatment market Key Players are:
1. AbbVie Inc.
2. Alimera Sciences Inc.
3. Allergan Inc.
4. Bausch & Lomb Incorporated.
5. Eyegate
6. Eyegate Pharmaceuticals Inc.
7. Novartis AG (Alcon Laboratories Inc.)
8. pSivida Corp.
9. Regeneron Pharmaceuticals Inc.
10. Santen Pharmaceutical Co. Ltd.
11. Valeant Pharmaceuticals International Inc.
12. Akorn Pvt. Ltd
13. Roche Ltd
14. Senju Pharmaceutical Co. Ltd
15. Bayer HealthCare Pharmaceutical LLC
16. Pfizer Pharmaceutical company
17. Cipla Ltd.
18. Ocular Therapeutix, Inc.
19. Kala Pharmaceuticals
20. AxeroVision, Inc.
21. Myvision Eyeclinic
22. John Musumeci Optical Pty Ltd
Frequently Asked questions
1. What is the market size of the Global Ocular Inflammation Treatment Market in 2022?
Ans. The market size Global market in 2022 was US$ 174.25 Million.
2. What are the different segments of the Global Ocular Inflammation Treatment Market?
Ans. The Global market is divided into treatment type, uvea, Pathophysiology and Distribution Channel.
3. What is the study period of this market?
Ans. The Global Ocular Inflammation Treatment Market will be studied from 2022 to 2029.
4. Which region is expected to hold the highest Global Ocular Inflammation Treatment Market share?
Ans. The Asia Pacific dominates the market share in the market.
5. What is the Forecast Period of Global Ocular Inflammation Treatment Market?
Ans. The Forecast Period of the market is 2023-2029 in the market.